Exhibit 99.1
Joshua P. McGinn, CEP Senior Vice President, Western Region Relationship Management American Stock Transfer & Trust Company, LLC One Embarcadero Center – Suite 566 San Francisco, CA 94111 Office: 415.835-1313 |
February 19, 2015
Alberta Securities Commission
British Columbia Securities Commission
Ontario Securities Commission
RE: Xenon Pharmaceuticals Inc.
Pursuant to a request from the above-mentioned reporting issuer, we wish to advise you of the following information in connection with its Annual Meeting of Shareholders:
Date of meeting: | May 4, 2015 |
Record date for notice: | March 17, 2015 |
Record date for voting: | March 17, 2015 |
Beneficial ownership determination date: | March 17, 2015 |
Securities entitled to notice: | Common Shares |
Securities entitled to vote: | Common Shares |
Issuer mailing directly to non objecting beneficial owners: | No |
Issuer will pay for objecting beneficial owner material distribution: | No |
Issuer using notice-and-access for registered investors: | No |
Issuer using notice-and-access for non-registered investors: | No |
Notice-and-access stratification criteria: | N/A |
Yours very truly,
Joshua P. McGinn
Senior Vice-President, Western Region
Relationship Management